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Background: Based on small studies with limited follow up, recent consensus guidelines for the management of hypertrophic cardiomyopathy 
(HCM) have suggested that late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) may be considered in resolving clinical 
decision making for risk stratification. We sought to determine whether the presence of LGE could predict all-cause mortality in a large cohort of 
HCM patients.
Methods: Consecutive patients with HCM undergoing LGE CMR at the Royal Brompton Hospital between Jan 2001 and Aug 2011 were followed up 
for all-cause mortality. HCM was diagnosed in accordance with current guidelines.
Results: A total of 802 patients (mean±SD age 55±15 yrs, 562 [70%] male) were studied with a median of 3.4 yrs (IQR 2.0-5.7) or 3135 patient-
years follow up. Overall, 565 patients (70%) exhibited LGE. During follow up, there were 35 deaths (6.2%) in the LGE group and 13 (5.5%) in the 
no LGE cohort (total mortality: 6.0%). There was no difference in survival between the two groups (p=0.34, Fig 1). LV ejection fraction was the only 
significant independent predictor of all-cause mortality (HR 0.957, CI: 0.933-0.982, p<0.001) on multivariate Cox proportional hazards modelling.
Conclusion: The presence of myocardial fibrosis as detected by LGE-CMR does not independently predict all-cause mortality in HCM. Large long-
term follow up studies are required to delineate the role of the amount of fibrosis in the risk stratification of HCM.
